Simpli- Automation and Neuro Force One Announce Commencement of Pre-Clinical Trials of Provectus Trademark AI-Powered Olfactory Sensor Technology

Scottsdale, AZ - June 3, 2024 - Simpli- Automation and Neuro Force One (NF1) proudly announce the initiation of pre-clinical trials for Provectus Trademark , an innovative AI-powered olfactory sensor technology developed by Simpli- Automation. This collaborative endeavor represents a signicant leap forward in health monitoring, diagnostics, and human performance enhancement.

Provectus Trademark , spearheaded by Simpli- Automation, aims to enhance health, wellness, remediation and human performance by providing holistic analyses of biological responses to various stimuli, including exercise, nutrition, stress, and environmental factors. By harnessing NASA-licensed research technologies, Provectus Trademark offers real-time insights into an elite athlete's health status and performance metrics.

Simpli- Automation, licensed by NASA for its advanced carbon nano-tube enabled olfactory analysis technology, the e-nose (electronic nose), integrates exclusive NASA research technologies with proprietary algorithms to measure and analyze biometric measurements obtained from human breath. In collaboration with NF1, Simpli- Automation seeks to validate precise breath analytic readings to scientically correlate Provectus Trademark analyses with human health, chronic diseases, nutrition, hydration deciencies, and human performance achievements.

Chris Campbell, CEO of Simpli- Automation, emphasizes the signicance of insights garnered from elite athletes: "Operating at peak performance, athletes provide benchmarks against which other population cohorts can be compared. Subsequent testing with a diverse range of participants will inform Simpli-'s device algorithms and the NF1.ai app. We are excited about our partnership with NF1 as they represent the gold standard of sports-science informed human performance via their NF1 Lab."

Neuro Force One CEO, Karim Amin, shares his excitement about the partnership: "NF1 is dedicated to advancing human performance, health, and wellness. Our collaboration with Simpli- represents a signicant step in validating cutting-edge technology to achieve these goals.

In phase one of Simpli- Automation's clinical trials, Provectus Trademark will capture breath biomarker measurements from Neuro Force One's elite coaches and athletes. These insights will not only inform Simpli-'s device algorithms but will also integrate with the NF1.ai app to generate prescriptive health, wellness, exercise, and nutrition recommendations through Simpli- and NF1.ai articial intelligence synergies.

About Simpli- Automation

Simpli-fi Automation is a cutting-edge technology company dedicated to revolutionizing health monitoring and diagnostics with Provectus Trademark , an AI-driven breath analyzer. By utilizing state of the art sensor technology for precise breath sample analysis, it offers invaluable insights into conditions like ketosis, diabetes, and metabolic disorders. This innovative solution empowers both individuals and healthcare professionals with convenient, non-invasive, and real-time monitoring capabilities, enhancing wellness management and promoting proactive healthcare practices. Simpli-fi Automation is dedicated to advancing healthcare, wellness, fitness, and human performance through transformative technology, laying the foundation for a healthier and more knowledgeable future for all.

About Neuro Force One

Neuro Force One is a pioneer in sports science-based holistic human performance. NF1 has established itself as a leader in the field, conducting research that informs proprietary programs and algorithms which are integrated into the Company's consumer available software application and associated ecosystem which serves various advanced health, wellness, fitness, and human performance goals of the general population to elite athletes. NF1 utilizes cutting-edge technology to tailor and individualize training methods for elite athletes competing at Olympic and professional levels, achieving championship-level results with 46 world and national titles / medals to their credit. The data collected and analyzed from these athletes, provides the basis for the NF1 and subsequent NF1.ai iOS and Android Apps.

Media Contact:

Simpli- Automation
James McNair
james@mcnairmarketing.us [mailto:james@mcnairmarketing.us]
(612) 834-1107

Neuro Force One
Jarret Eaton
jarret@neuroforceone.com [mailto:jarret@neuroforceone.com]
(215) 620-8818
Media Contact
Company Name: Simpli-fi Automation
Contact Person: James McNair
Email: Send Email [http://www.universalpressrelease.com/?pr=simpli-automation-and-neuro-force-one-announce-commencement-of-preclinical-trials-of-provectus-aipowered-olfactory-sensor-technology]
Phone: (612) 834-1107
Country: United States
Website: https://www.mcnairmarketing.us/



This release was published on openPR.